Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa

被引:33
|
作者
Xipell, Marc [1 ]
Bodro, Marta [1 ]
Marco, Francesc [2 ]
Losno, Ricardo A. [1 ]
Cardozo, Celia [1 ]
Soriano, Alex [1 ]
机构
[1] Univ Barcelona, Hosp Clin IDIBAPS, Dept Infect Dis, Villarroel 170, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin ISGLOBAL, Dept Microbiol, Barcelona, Spain
关键词
AVIBACTAM; MORTALITY;
D O I
10.1016/j.ijantimicag.2016.11.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:266 / 268
页数:4
相关论文
共 50 条
  • [31] Use of topical colistin in bacterial keratitis caused by extensively drug-resistant Pseudomonas Aeruginosa: a case report
    Maticorena-Quevedo, Jesus
    Patino-Valderrama, Lia
    Arellano-Caro, Karin
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2023, 86 (04) : 384 - 387
  • [32] Jumbo phages are active against extensively drug-resistant eyedrop-associated Pseudomonas aeruginosa infections
    Cobian Guemes, Ana Georgina
    Ghatbale, Pooja
    Blanc, Alisha N.
    Morgan, Chase J.
    Garcia, Andrew
    Leonard, Jesse
    Huang, Lina
    Kovalick, Grace
    Proost, Marissa
    Chiu, Megan
    Kuo, Peiting
    Oh, Joseph
    Karthikeyan, Smruthi
    Knight, Rob
    Pogliano, Joe
    Schooley, Robert T.
    Pride, David T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
  • [33] Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal - A cross-sectional and retrospective observational study
    Mendes Pedro, Diogo
    Paulo, Sergio Eduardo
    Santos, Carla Mimoso
    Fonseca, Ana Bruschy
    Melo Cristino, Jose
    Pereira, alvaro Ayres
    Caneiras, Catia
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [34] Utilizing Ceftazidime/Avibactam Therapeutic Drug Monitoring in the Treatment of Neurosurgical Meningitis Caused by Difficult-to-Treat Resistant Pseudomonas aeruginosa and KPC-Producing Enterobacterales
    Yasmin, Mohamad
    Nutman, Amir
    Wang, Lu
    Marshall, Steven
    Chen, Ke
    Wang, Jiping
    Yahav, Dafna
    Lupinsky, Liad
    Hujer, Andrea M.
    Bhimraj, Adarsh
    van Duin, David
    Li, Jian
    Bonomo, Robert A.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [35] In-vitro Efficacy of Ceftazidime in Combinations with Meropenem, Piperacillin/Tazobactam, Amikacin and Ciprofloxacin against Extensively Drug-Resistant Pseudomonas aeruginosa
    Hannan, Abdul
    Gondal, Aamir Jamal
    Saleem, Sidrah
    Arshad, Muhammad Usman
    Lateef, Waqas
    PAKISTAN JOURNAL OF ZOOLOGY, 2014, 46 (04) : 1111 - 1116
  • [36] A case of meningitis due to extensively drug-resistant Pseudomonas aeruginosa imported through medical evacuation: genomic and environmental investigation
    Baba, Hiroaki
    Kanamori, Hajime
    Katsumi, Makoto
    Sato, Takami
    Chida, Takae
    Ikeda, Shinobu
    Suzuki, Yuki
    Yano, Hisakazu
    Tokuda, Koichi
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (06)
  • [37] Draft Genome Sequence of the Extensively Drug-Resistant Pseudomonas aeruginosa Clinical Isolate TUEPA7472
    Miess, Henrike
    Jahanshah, Ghazaleh
    Broetz-Oesterhelt, Heike
    Willmann, Matthias
    Peter, Silke
    Gross, Harald
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2018, 7 (12):
  • [38] Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs
    Meschiari, Marianna
    Orlando, Gabriella
    Kaleci, Shaniko
    Bianco, Vincenzo
    Sarti, Mario
    Venturelli, Claudia
    Mussini, Cristina
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [39] The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings
    Jones, Frank
    Hu, Yanmin
    Coates, Anthony
    ANTIBIOTICS-BASEL, 2022, 11 (03):
  • [40] Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients
    Zavrelova, Alzbeta
    Sima, Martin
    Malakova, Jana
    Rozsivalova, Petra
    Paterova, Pavla
    Zak, Pavel
    Visek, Benjamin
    Michalickova, Danica
    Slanar, Ondrej
    Radocha, Jakub
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (04) : 1452 - 1461